Plasma HVA and MHPG in psychiatric patients with renal failure and levodopa-treated Parkinson's disease.
作者信息
Bowers M B
机构信息
Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06519, USA.
出版信息
J Neuropsychiatry Clin Neurosci. 1996 Fall;8(4):450-2. doi: 10.1176/jnp.8.4.450.
PMID:9116484
Abstract
Plasma homovanillic acid (HVA), but not plasma 3-methoxy-4-hydroxyphenylglycol (MHPG), was substantially increased in 4 patients undergoing hemodialysis, 3 patients with chronic renal failure, and 3 patients receiving carbidopa/levodopa for Parkinson's disease. These conditions should be considered in psychiatric research involving plasma HVA.
摘要
Zotero 插件